{"nct_id":"NCT03685344","title":"Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma","status":"TERMINATED","status_verified_date":"2021-09","start_date":"2019-02-04","start_date_type":"ACTUAL","primary_completion_date":"2020-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ADCT"]}